Definition of recurrent miscarriage updated The revised definition, along with other evidence-based recommendations, appear in new clinical guidelines for early pregnancy loss.
Act early on eating disorder warning signs: Study New Australian research aims to help GPs and parents to close the gap between onset and diagnosis of a child’s eating disorder.
Decade-first guidance on FASD diagnosis The ‘groundbreaking’ guidelines aim to improve assessment and diagnosis of the disorder and arm GPs with more confidence.
Teens’ contraception needs left wanting in regional areas: Study Rural GPs say knowledge and access remain barriers to contraception options for teens. However, gaps also exist among GPs.
Obesity management needs medications on PBS: RACGP The college’s new obesity position statement calls for extra funding to treat the complex condition and for care to be made affordable for more patients.
Blood test shows promise for birth risk early detection A new rapid sensor test can detect pregnancy complications such as gestational diabetes and preeclampsia, as early as 11 weeks.
Wegovy approved for cutting cardiovascular disease risk The TGA has approved semaglutide (sold as Wegovy) as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in overweight and obese adults.
World experts urge overhaul of obesity definition The Global Commission on Clinical Obesity says diagnosis must change, setting out new criteria, categories, and calling on doctors to go ‘beyond BMI’.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
Study links semaglutide and suicidal ideation risk There are calls for urgent investigation into its impact on mental health, but GPs are urging caution when interpreting the research.